Skip to main content

Table 2 Summary risk ratios (RRs) and 95% confidence interval (CI) for the association between breast cancer risk and light at night exposure comparing the highest versus the lowest exposure categories for overall study population, outdoor and indoor exposure with selected subgroups

From: Light at night and risk of breast cancer: a systematic review and dose–response meta-analysis

Breast cancer

All studies

Outdoor

Indoor

n

RR (95% CI)

I2 (%)

n

RR (95% CI)

I2 (%)

n

RR (95% CI)

I2 (%)

All women

17

1.11 (1.07–1.15)

0.0

7

1.11 (1.07–1.16)

0.0

11

1.08 (1.00–1.17)

6.5

Study design

         

 Cohort/case-cohort studies

9

1.11 (1.07–1.15)

0.0

8

1.11 (1.07–1.16)

0.0

4

1.05 (0.96–1.15)

0. 0

 Case–control studies

8

1.11 (0.97–1.28)

31.5

1

0.95 (0.71–1.28)

-

7

1.14 (0.98–1.34)

34.2

Menopausal status

         

 Premenopausal

8

1.16 (1.04–1.28)

2.3

4

1.22 (1.08–1.39)

0.0

4

1.04 (0.88–1.23)

0.0

 Postmenopausal

9

1.07 (1.02–1.13)

0.0

5

1.07 (1.00–1.14)

5.9

4

1.08 (0.95–1.23)

4.3

BMI

         

 < 25 kg/m2

2

1.17 (1.00–1.36)

38.9

2

1.17 (1.00–1.36)

39.0

-

-

  ≥  25 kg/m2

2

1.07 (0.87–1.32)

53.8

2

1.07 (0.87–1.32)

53.8

-

Estrogen receptor status

         

 ER + 

7

1.09 (1.02–1.17)

0.0

4

1.12 (0.95–1.32)

44.8

3

1.06 (0.95–1.18)

0.0

 ER –

7

1.07 (0.92–1.23)

0.0

4

1.12 (0.92–1.35)

0.0

3

1.01 (0.81–1.25)

0.0

LAN/sunshine hours

         

 < 2000 h

3

0.99 (0.89–1.11)

0.0

2

0.96 (0.80–1.16)

0.0

1

1.01 (0.88–1.15)

 2000–3000 h

11

1.12 (1.08–1.17)

0.0

5

1.12 (1.07–1.17)

0.0

7

1.13 (1.02–1.25)

0.0

 > 3000 h

3

1.30 (1.11–1.52)

15.4

1

1.47 (1.00–2.17)

3

1.11 (0.79–1.56)

66.3

Equinoctial UVB

         

 0.0–0.58 W/m2

3

0.97 (0.87–1.08)

0 .0

2

0.91 (0.76–1.09)

0.0

1

1.01 (0.88–1.15)

 0.58–1.15 W/m2

1

1.27 (0.89–1.82)

1

1.47 (1.00–2.17)

1

1.01 (0.60–1.70)

 1.15–1.73 W/m2

13

1.15 (1.10–1.19)

5.6

5

1.12 (1.07–1.17)

0.0

9

1.20 (1.12–1.27)

0.0

  1. BMI body mass index, CI confidence interval, ER estrogen receptor, h. hours, I2 (%) heterogeneity, LAN l ight at night, n number of studies, RR risk ratio, UVB ultraviolet B